Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LFWDNASDAQ:NRXSNASDAQ:VERONASDAQ:VVOS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLFWDReWalk Robotics$1.49-0.7%$1.58$1.22▼$5.28$15.84M1.51676,927 shs81,572 shsNRXSNeurAxis$2.40-1.6%$2.07$1.33▼$3.78$17.32M3.4617,810 shs41,027 shsVEROVenus Concept$2.51+1.2%$3.32$2.16▼$17.49$3.57M0.25379,124 shs88,151 shsVVOSVivos Therapeutics$2.68+1.9%$2.94$1.91▼$6.28$15.79M7.31451,721 shs38,299 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLFWDReWalk Robotics-0.67%+4.20%-16.76%+0.68%-68.63%NRXSNeurAxis-1.64%+33.70%+14.29%-20.00%-26.15%VEROVenus Concept+1.21%-7.38%-8.73%-29.88%-66.65%VVOSVivos Therapeutics+1.90%+21.82%-13.83%-34.95%+3.47%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLFWDReWalk Robotics2.5658 of 5 stars3.54.00.00.02.00.01.3NRXSNeurAxisN/AN/AN/AN/AN/AN/AN/AN/AVEROVenus Concept0.9176 of 5 stars0.02.00.00.03.03.30.0VVOSVivos Therapeutics2.7764 of 5 stars3.55.00.00.03.00.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLFWDReWalk Robotics 3.00Buy$9.00504.03% UpsideNRXSNeurAxis 0.00N/AN/AN/AVEROVenus Concept 0.00N/AN/AN/AVVOSVivos Therapeutics 3.00Buy$6.10127.61% UpsideCurrent Analyst Ratings BreakdownLatest VERO, LFWD, VVOS, and NRXS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/15/2025VVOSVivos TherapeuticsAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$6.60 ➝ $6.204/1/2025VVOSVivos TherapeuticsAlliance Global PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy3/11/2025LFWDReWalk RoboticsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$4.50 ➝ $4.003/11/2025LFWDReWalk RoboticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$13.00 ➝ $13.002/20/2025LFWDReWalk RoboticsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$6.00 ➝ $4.502/20/2025LFWDReWalk RoboticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$13.00 ➝ $13.002/10/2025LFWDReWalk RoboticsLaidlawSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$10.00(Data available from 4/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLFWDReWalk Robotics$25.66M0.62N/AN/A$5.42 per share0.27NRXSNeurAxis$2.69M6.45N/AN/A($0.27) per share-8.89VEROVenus Concept$64.83M0.06N/AN/A($2.43) per share-1.03VVOSVivos Therapeutics$15.03M1.05N/AN/A$0.22 per share12.18Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLFWDReWalk Robotics-$22.13M-$3.31N/AN/AN/A-77.21%-43.02%-31.53%5/13/2025 (Estimated)NRXSNeurAxis-$14.63M-$1.20N/A∞N/A-492.76%N/A-641.25%5/19/2025 (Estimated)VEROVenus Concept-$37.25M-$77.35N/A∞N/A-74.62%N/A-47.46%5/15/2025 (Estimated)VVOSVivos Therapeutics-$13.58M-$2.91N/AN/AN/A-86.19%-335.04%-93.58%5/13/2025 (Estimated)Latest VERO, LFWD, VVOS, and NRXS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/21/2025Q1 2025LFWDReWalk Robotics-$0.33N/AN/AN/AN/AN/A5/13/2025Q1 2025VVOSVivos Therapeutics-$0.41N/AN/AN/A$3.63 millionN/A3/31/2025Q4 2024VEROVenus Concept-$10.0089-$11.23-$1.2211-$11.23$16.99 million$15.77 million3/27/2025Q4 2024VVOSVivos Therapeutics-$0.43-$0.28+$0.15-$0.28$3.89 million$3.70 million3/7/2025Q4 2024LFWDReWalk Robotics-$0.20-$1.73-$1.53-$1.73$7.30 million$7.55 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLFWDReWalk RoboticsN/AN/AN/AN/AN/ANRXSNeurAxisN/AN/AN/AN/AN/AVEROVenus ConceptN/AN/AN/AN/AN/AVVOSVivos TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLFWDReWalk RoboticsN/A2.651.90NRXSNeurAxisN/A0.240.23VEROVenus Concept2.831.861.18VVOSVivos TherapeuticsN/A1.441.44Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLFWDReWalk Robotics26.76%NRXSNeurAxis11.77%VEROVenus Concept87.41%VVOSVivos Therapeutics26.35%Insider OwnershipCompanyInsider OwnershipLFWDReWalk Robotics2.50%NRXSNeurAxis15.20%VEROVenus Concept48.96%VVOSVivos Therapeutics3.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLFWDReWalk Robotics6010.63 million10.36 millionOptionableNRXSNeurAxis197.22 million6.09 millionNot OptionableVEROVenus Concept4101.42 million3.70 millionNot OptionableVVOSVivos Therapeutics1605.89 million5.71 millionOptionableVERO, LFWD, VVOS, and NRXS HeadlinesRecent News About These CompaniesVivos to acquire sleep centerApril 17, 2025 | hmenews.comVivos Therapeutics announces agreement to acquire operating assets of SCNApril 17, 2025 | markets.businessinsider.comVivos Opens New Sleep CenterApril 16, 2025 | baystreet.caVivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in NevadaApril 16, 2025 | globenewswire.comVivos Therapeutics price target lowered to $5.50 from $6 at Alliance Global PartnersApril 2, 2025 | markets.businessinsider.comVivos Therapeutics’ Earnings Call Highlights Growth and ExpansionApril 1, 2025 | tipranks.comVivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.comVivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call TranscriptApril 1, 2025 | seekingalpha.comVivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue EstimatesMarch 31, 2025 | zacks.comVivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational UpdateMarch 31, 2025 | globenewswire.com4VVOS : Earnings Outlook For Vivos TherapeuticsMarch 28, 2025 | benzinga.comVivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference CallMarch 28, 2025 | globenewswire.comVivos Therapeutics expands strategic alliance with Rebis HealthFebruary 25, 2025 | markets.businessinsider.comVivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions NationwideFebruary 24, 2025 | markets.businessinsider.comVivos Therapeutics sees strong adoption of OSA treatment, expands strategic allianceFebruary 24, 2025 | proactiveinvestors.comVivos Therapeutics Enters Market Offering Agreement with WainwrightFebruary 14, 2025 | tipranks.comVivos Therapeutics files $50M mixed securities shelfFebruary 11, 2025 | markets.businessinsider.comVivos Therapeutics files to sell 854,332 shares of common stock for holdersJanuary 22, 2025 | markets.businessinsider.comBest Momentum Stocks to Buy for January 8thJanuary 8, 2025 | zacks.comNew Strong Buy Stocks for January 8thJanuary 8, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVERO, LFWD, VVOS, and NRXS Company DescriptionsReWalk Robotics NASDAQ:LFWD$1.49 -0.01 (-0.67%) Closing price 04/28/2025 04:00 PM EasternExtended Trading$1.51 +0.02 (+1.61%) As of 04/28/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.NeurAxis NASDAQ:NRXS$2.40 -0.04 (-1.64%) Closing price 04/28/2025 03:54 PM EasternExtended Trading$2.32 -0.08 (-3.17%) As of 04/28/2025 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.Venus Concept NASDAQ:VERO$2.51 +0.03 (+1.21%) Closing price 04/28/2025 04:00 PM EasternExtended Trading$2.46 -0.05 (-2.19%) As of 04/28/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.Vivos Therapeutics NASDAQ:VVOS$2.68 +0.05 (+1.90%) Closing price 04/28/2025 04:00 PM EasternExtended Trading$2.72 +0.04 (+1.49%) As of 04/28/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Rebounds After Strong Earnings and Buyback Announcement Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret? The Bear Market Has Only Just Started - Here's Why MarketBeat Week in Review – 04/21 - 04/25 3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S. PepsiCo’s Stock Price is Disconnected From Reality: Time to Buy Bears Can Reap Big Benefits With These 3 Short ETF Bets Why Institutions Are Buying Super Micro Computer Stock Again Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
